LIP
AZN icon

Lighthouse Investment Partners’s AstraZeneca AZN Stock Holding History

Lighthouse Investment Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-340,000
Closed -$53M – 435
2024
Q2 		$53M Buy
340,000
+260,000
+325% +$39.1M 2.11% 3
2024
Q1 		$10.8M Buy
+80,000
New +$10.6M 0.5% 44

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Lighthouse Investment Partners's AZN Position: Q1 2026 in Review

Lighthouse Investment Partners opened a new position in AstraZeneca (AZN) in Q1 2026: 19,335 shares worth $3.81M. The stake represents 0.13% of the portfolio and ranks #234 among its holdings. This is a return to the name: Lighthouse Investment Partners previously reported a position in AZN as recently as Q3 2025.

Lighthouse Investment Partners first reported a position in AZN in Q4 2023 and has held it in 7 quarters since. The position peaked at $4.96M in Q2 2024. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Lighthouse Investment Partners held 19,335 shares of AstraZeneca worth $3.81M as of Q1 2026.
  • AstraZeneca was a new Lighthouse Investment Partners position in Q1 2026.
  • AstraZeneca made up 0.13% of Lighthouse Investment Partners's portfolio in Q1 2026, its #234 holding.
  • Lighthouse Investment Partners first reported a position in AstraZeneca in Q4 2023 and has held it in 7 quarters since.
  • Lighthouse Investment Partners's AstraZeneca position peaked at $4.96M in Q2 2024.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.